SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (4890)11/6/2001 7:44:37 PM
From: Miljenko Zuanic  Respond to of 52153
 
<<It's somewhat less clear to me why the profitable biotechs keep so much cash on hand. Maybe to stop their Compensation Committees from whining about not having enough cash to give executives big bonuses.>>

Two-three slow Q, and exponential grow in R&D expenditure, one can *eat* cash very quickly. Many profitable bios have net revenue of few $M to few $10M, far from secure level.

Miljenko